Susie Nazzaro is an access to medicines expert with experience across the not-for-profit and private sectors. She is currently a director in the Global Market Access team at Seagen, the industry leader in antibody-drug conjugates for treatment of cancer. She heads up the early pipeline access function, developing the company’s strategy to ensure early pipeline clinical development plans maximize patient access. Previously, she led efforts to ensure access to essential health products for patients in low- and middle-income countries at the Bill and Melinda Gates Foundation, including all new product introduction for the malaria program. She led the launch of a comprehensive package of novel tools to treat p.vivax malaria as well as the transition of the sub-Saharan African market away from less effective insecticides to new long-lasting insecticide treated nets for the prevention of malaria. She was also part of the team managing the foundation’s engagement with the Global Fund for over a decade, serving as the Chief of Staff and Senior Advisor to the Vice-Chair of the Global Fund Board, and served on the UNITAID Board from 2010-2016. She currently serves as an advisor to the Medicines for Malaria Venture, SEMA Reproductive Health, and Evidence Action. She has also been a consultant at the World Bank and a Peace Corps volunteer in Madagascar.
She holds a B.A from Wellesley College and an M.Sc. in development economics from the London School of Economics. She lives in Seattle with her husband Cory and their two children Ozzy (11) and Vera (7). When not chasing her small people around, she can be found cheering for the Seattle Sounders and Tottenham Hotspur or spending too much money on records.